Volume 5 Supplement 1
Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)
Meeting abstracts
12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Go to conference site.
Bethesda, MD, USA26-27 April, 2010
Page 2 of 2
-
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A51
-
Malignancies in HIV
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A52 -
Malignant lymphoma incidence and HIV-related lymphoma subtypes in the Western Cape of South Africa, 2002-2009
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A53 -
Malignant lymphoma subgroups from Zaria, Nigeria, reveal absence of HIV/AIDS-related plasmablastic lymphomas and HHV-8-related lymphoproliferative disorders
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A54 -
MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A55 -
Mortality after cancer diagnosis among HIV-infected individuals in the CFAR Network of Integrated Clinical Systems (CNICS)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A56 -
Non-AIDS-defining cancer mortality among people with AIDS in Italy
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A57 -
Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A58 -
Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A59 -
Phase IIA trial of 1% topical cidofovir for treatment of high-grade perianal squamous intraepithelial neoplasia in HIV-infected men and women (AMC046)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A60 -
Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A61 -
Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A62 -
Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A63 -
Prevalence of HIV among general surgical patients in southeastern Nigeria
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A64 -
Prevalence of HIV-associated malignancies among PLWHAs accessing HIV services in Abia State, Nigeria
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A65 -
Preventing HHV-8 transmission and Kaposi’s sarcoma (KS) risk prediction and prognostication in resource-poor countries
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A66 -
Progression of cervical neoplasia in HIV-seropositive women with and without antiretroviral therapy in Johannesburg, South Africa
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A67 -
Reasons for not adhering to cervical cancer screening guidelines and HPV knowledge among HIV indeterminate midlife women (50-64 years old) whose last Pap test was >6 years ago
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A68 -
Relationship between salivary shedding and seropositivity for Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A69 -
Risk of anal cancer in HIV-infected patients and HIV-uninfected controls in North America
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A70 -
Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A71 -
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A72 -
Role of TP53 polymorphisms in sub-Saharan mucosal cancers
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A73 -
T cell immunosenescence is associated with the presence of Kaposi’s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A74 -
The angiogenic properties of Kaposi's sarcoma-associated herpesvirus encoded G-protein coupled receptor are reduced by flavopiridol, an inhibitor of cyclin-dependent kinase 9
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A75 -
The approach to individualized prediction of human papillomavirus (HPV) infection persistence/clearance in HIV-1-positive adolescent girls based on dynamics of CD4+ counts, viral load, and HAART
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A76 -
The HIV nef protein within ARL is genetically and structurally distinct from those in the brain of patients with HAD
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A77 -
The impact of aging on cancer burden in people with HIV/AIDS
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A78 -
The Kaposi's sarcoma-associated herpesvirus E3 ubiquitin ligase K5 acts as a novel oncogene, altering cellular metabolism and signaling: implications for tumorigenesis
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A79 -
The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A80 -
The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A81 -
TNFAIP3(A20) genetic alterations in AIDS-related lymphomas
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A82 -
Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A83 -
Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A84 -
Upregulation of p18Ink4c expression by HPV E6 via p53-miR-34a pathway
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A85 -
Use of mobile telemedicine for cervical cancer screening of HIV-positive women in Gaborone, Botswana
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A86
-
Affiliated with
-
Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.1
5-year Journal Impact Factor: 3.3
Source Normalized Impact per Paper (SNIP): 0.810
SCImago Journal Rank (SJR): 0.424Speed 2024
Submission to first editorial decision (median days): 8
Submission to acceptance (median days): 78Usage 2024
Downloads: 638,642
Altmetric mentions: 249
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.